<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30254998</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>28</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Print">2287-8572</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>61</Volume>                    <Issue>5</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Obstetrics &amp; gynecology science</Title>                <ISOAbbreviation>Obstet Gynecol Sci</ISOAbbreviation>            </Journal>            <ArticleTitle>The effect of tamoxifen therapy on the endometrium and ovarian cyst formation in patients with breast cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>615-620</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.5468/ogs.2018.61.5.615</ELocationID>            <Abstract>                <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To evaluate the effect of tamoxifen on female reproductive organs in women with breast cancer.</AbstractText>                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">We retrospectively reviewed the medical records of 309 women with breast cancer who were currently receiving tamoxifen and undergoing regular gynecological examination.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">We evaluated 92 pre- and 217 postmenopausal women. The prevalence of endometrial thickening was 12% in the pre- and 10.6% in the postmenopausal group. An endometrial biopsy was performed in 43 women and confirmed endometrial cancer in 1, endometrial polyps in 14, and endometrial hyperplasia in 4 women. Transvaginal ultrasonography showed 25 cases of newly developed ovarian cysts. Most ovarian cysts had disappeared during follow-up.</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">Tamoxifen use in women with breast cancer causes few complications and is considered safe for female reproductive organs in case of regular gynecological examination.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Lee</LastName>                    <ForeName>Seul</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Obstetrics and Gynecology, School of Medicine; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kim</LastName>                    <ForeName>Yun Hwa</ForeName>                    <Initials>YH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Obstetrics and Gynecology, School of Medicine; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kim</LastName>                    <ForeName>Seung Chul</ForeName>                    <Initials>SC</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Obstetrics and Gynecology, School of Medicine; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Joo</LastName>                    <ForeName>Jong Kil</ForeName>                    <Initials>JK</Initials>                    <Identifier Source="ORCID">https://orcid.org/0000-0002-6338-1512</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Obstetrics and Gynecology, School of Medicine; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Seo</LastName>                    <ForeName>Dong Suh</ForeName>                    <Initials>DS</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Obstetrics and Gynecology, School of Medicine; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kim</LastName>                    <ForeName>Ki Hyung</ForeName>                    <Initials>KH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Obstetrics and Gynecology, School of Medicine; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lee</LastName>                    <ForeName>Kyu Sup</ForeName>                    <Initials>KS</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Obstetrics and Gynecology, School of Medicine; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>13</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Korea (South)</Country>            <MedlineTA>Obstet Gynecol Sci</MedlineTA>            <NlmUniqueID>101602614</NlmUniqueID>            <ISSNLinking>2287-8572</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>J Reprod Med. 1990 Mar;35(3):299-300</RefSource>                <PMID Version="1">2157841</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2002 Jun 15;94(12):3101-6</RefSource>                <PMID Version="1">12115340</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol. 2000 Aug;78(2):181-6</RefSource>                <PMID Version="1">10926800</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol. 1997 Aug;66(2):233-7</RefSource>                <PMID Version="1">9264568</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol. 2004 Aug;94(2):256-66</RefSource>                <PMID Version="1">15297160</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Biol Ther. 2014;15(12):1586-7</RefSource>                <PMID Version="1">25535893</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann N Y Acad Sci. 1994 Sep 30;734:310-21</RefSource>                <PMID Version="1">7978932</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Obstet Gynecol. 1999 Feb;180(2 Pt 1):340-1</RefSource>                <PMID Version="1">9988797</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Lett. 2013 Apr;5(4):1305-1310</RefSource>                <PMID Version="1">23599784</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Gynecol Oncol. 2008 Dec;19(4):256-60</RefSource>                <PMID Version="1">19471651</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res Treat. 2015 Oct;47(4):583-90</RefSource>                <PMID Version="1">25687860</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol. 1996 Jan;60(1):54-8</RefSource>                <PMID Version="1">8557228</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Gynecol Pathol. 1996 Apr;15(2):152-7</RefSource>                <PMID Version="1">8786205</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Obstet Gynecol. 1993 Aug;82(2):165-9</RefSource>                <PMID Version="1">8393156</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Jpn J Clin Oncol. 2005 Oct;35(10):607-11</RefSource>                <PMID Version="1">16254040</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Invest. 1979 Aug;64(2):398-404</RefSource>                <PMID Version="1">110834</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2000 Oct 15;18(20):3464-70</RefSource>                <PMID Version="1">11032586</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast neoplasms</Keyword>            <Keyword MajorTopicYN="N">Endometrium</Keyword>            <Keyword MajorTopicYN="N">Ovary</Keyword>            <Keyword MajorTopicYN="N">Tamoxifen</Keyword>        </KeywordList>        <CoiStatement>Conflict of interest: No potential conflict of interest relevant to this article was reported.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2017</Year>                <Month>10</Month>                <Day>10</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>01</Month>                <Day>12</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>01</Month>                <Day>26</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30254998</ArticleId>            <ArticleId IdType="doi">10.5468/ogs.2018.61.5.615</ArticleId>            <ArticleId IdType="pmc">PMC6137019</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>